JP2019505185A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019505185A5 JP2019505185A5 JP2018531159A JP2018531159A JP2019505185A5 JP 2019505185 A5 JP2019505185 A5 JP 2019505185A5 JP 2018531159 A JP2018531159 A JP 2018531159A JP 2018531159 A JP2018531159 A JP 2018531159A JP 2019505185 A5 JP2019505185 A5 JP 2019505185A5
- Authority
- JP
- Japan
- Prior art keywords
- hmwk
- sample
- hae
- peptide
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022096962A JP7425117B2 (ja) | 2015-12-15 | 2022-06-16 | 完全長の高分子量キニノーゲン（ｈｍｗｋ）と切断されたｈｍｗｋとを区別するためのペプチド定量アッセイ |
| JP2024005910A JP7758766B2 (ja) | 2015-12-15 | 2024-01-18 | 完全長の高分子量キニノーゲン（ｈｍｗｋ）と切断されたｈｍｗｋとを区別するためのペプチド定量アッセイ |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562267734P | 2015-12-15 | 2015-12-15 | |
| US62/267,734 | 2015-12-15 | ||
| PCT/US2016/066936 WO2017106504A1 (en) | 2015-12-15 | 2016-12-15 | Peptide quantitation assay for differentiating full-length high molecular weight kininogen (hmwk) and cleaved hmwk |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022096962A Division JP7425117B2 (ja) | 2015-12-15 | 2022-06-16 | 完全長の高分子量キニノーゲン（ｈｍｗｋ）と切断されたｈｍｗｋとを区別するためのペプチド定量アッセイ |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019505185A JP2019505185A (ja) | 2019-02-28 |
| JP2019505185A5 true JP2019505185A5 (enExample) | 2020-01-30 |
| JP7092669B2 JP7092669B2 (ja) | 2022-06-28 |
Family
ID=57794352
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018531159A Active JP7092669B2 (ja) | 2015-12-15 | 2016-12-15 | 完全長の高分子量キニノーゲン（ｈｍｗｋ）と切断されたｈｍｗｋとを区別するためのペプチド定量アッセイ |
| JP2022096962A Active JP7425117B2 (ja) | 2015-12-15 | 2022-06-16 | 完全長の高分子量キニノーゲン（ｈｍｗｋ）と切断されたｈｍｗｋとを区別するためのペプチド定量アッセイ |
| JP2024005910A Active JP7758766B2 (ja) | 2015-12-15 | 2024-01-18 | 完全長の高分子量キニノーゲン（ｈｍｗｋ）と切断されたｈｍｗｋとを区別するためのペプチド定量アッセイ |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022096962A Active JP7425117B2 (ja) | 2015-12-15 | 2022-06-16 | 完全長の高分子量キニノーゲン（ｈｍｗｋ）と切断されたｈｍｗｋとを区別するためのペプチド定量アッセイ |
| JP2024005910A Active JP7758766B2 (ja) | 2015-12-15 | 2024-01-18 | 完全長の高分子量キニノーゲン（ｈｍｗｋ）と切断されたｈｍｗｋとを区別するためのペプチド定量アッセイ |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US11668718B2 (enExample) |
| EP (2) | EP3390439B1 (enExample) |
| JP (3) | JP7092669B2 (enExample) |
| KR (2) | KR102874711B1 (enExample) |
| CN (1) | CN108602877A (enExample) |
| AU (3) | AU2016372159B2 (enExample) |
| CA (1) | CA3008621A1 (enExample) |
| CO (1) | CO2018007216A2 (enExample) |
| EA (1) | EA201891414A1 (enExample) |
| IL (4) | IL297850B2 (enExample) |
| MX (2) | MX2018007493A (enExample) |
| NZ (1) | NZ743482A (enExample) |
| WO (1) | WO2017106504A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT3060908T (pt) | 2013-10-21 | 2021-05-27 | Dyax Corp | Diagnóstico e tratamento de doenças autoimunes |
| KR20250066486A (ko) | 2013-10-21 | 2025-05-13 | 다케다 파머수티컬 컴패니 리미티드 | 혈장 칼리크레인 시스템 바이오마커를 결정하기 위한 검정법 |
| JP6903648B2 (ja) | 2015-10-19 | 2021-07-14 | ダイアックス コーポレーション | 切断高分子量キニノーゲンを検出するイムノアッセイ |
| EP3390439B1 (en) | 2015-12-15 | 2025-03-12 | Takeda Pharmaceutical Company Limited | Peptide quantitation assay for differentiating full-length high molecular weight kininogen (hmwk) and cleaved hmwk |
| WO2018225830A1 (ja) * | 2017-06-08 | 2018-12-13 | 国立大学法人宮崎大学 | 肺がんの検出方法 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5047323A (en) * | 1986-01-22 | 1991-09-10 | Temple University Of The Commonwealth System Of Higher Education | Method for detecting human kininogen using monoclonal antibodies thereto |
| JP2603487B2 (ja) | 1987-11-26 | 1997-04-23 | 大日本製薬株式会社 | ガンに罹患している疑いのあるヒトをスクリーニングする方法 |
| JPH08208692A (ja) | 1994-09-28 | 1996-08-13 | Sumitomo Pharmaceut Co Ltd | 新規な細胞接着抑制ペプチド誘導体 |
| JP3073439B2 (ja) * | 1996-02-08 | 2000-08-07 | 雪印乳業株式会社 | 骨形成促進及び骨吸収防止剤 |
| AU1521500A (en) | 1998-11-10 | 2000-05-29 | W. Robert Colman | Inhibition of angiogenesis by peptide analogs of high molecular weight kininogendomain |
| US20060154319A1 (en) | 1999-04-29 | 2006-07-13 | Flodgaard Hans J | Inhibition of bradykinin release |
| WO2001034195A1 (en) | 1999-11-12 | 2001-05-17 | Temple University Of The Commonwealth System Of Higher Education | Inhibition of angiogenesis by antibodies against high molecular weight kininogen domain 5 |
| CA2478962A1 (en) | 2002-03-15 | 2003-09-25 | Attenuon, Llc | Cell surface tropomyosin as a target of angiogenesis inhibition |
| CN1858243A (zh) | 2005-04-30 | 2006-11-08 | 安徽省生物医学研究所 | 一种预测血管紧张素ii受体拮抗剂类降压药药物作用的方法及其应用 |
| EP2216651A4 (en) * | 2007-10-18 | 2010-12-01 | Miyazaki Prefectural Ind Suppo | BIOMARKERS FOR THE DIAGNOSIS OF LIVER DISEASE |
| JP5348595B2 (ja) | 2008-07-07 | 2013-11-20 | 日本臓器製薬株式会社 | 線維筋痛症の検査法 |
| GB0821721D0 (en) | 2008-11-27 | 2008-12-31 | Hansa Medical Ab | Antimicrobial therapy |
| DK3173792T3 (da) | 2009-03-30 | 2019-08-05 | Novartis Ag | Crp neo-epitop fibrose-assay |
| JP5714285B2 (ja) | 2010-09-29 | 2015-05-07 | 株式会社プロトセラ | 妊娠高血圧症候群マーカーおよびそれを用いた診断 |
| CN102558329A (zh) | 2010-12-10 | 2012-07-11 | 中国人民解放军军事医学科学院生物医学分析中心 | 一组特异性多肽及其在制备肺癌早期诊断试剂中的用途 |
| LT2831113T (lt) | 2012-03-28 | 2018-06-25 | Sanofi | Antikūnai prieš bradikinino b1 receptoriaus ligandus |
| CN111044725B (zh) * | 2013-01-20 | 2024-03-29 | 武田药品工业株式会社 | 缓激肽介导的病症的评估和治疗 |
| JP2016188761A (ja) | 2013-08-23 | 2016-11-04 | 国立研究開発法人国立国際医療研究センター | 糖尿病腎症の発症または発症リスクの検出方法及びキット |
| KR20250066486A (ko) * | 2013-10-21 | 2025-05-13 | 다케다 파머수티컬 컴패니 리미티드 | 혈장 칼리크레인 시스템 바이오마커를 결정하기 위한 검정법 |
| WO2015120036A1 (en) * | 2014-02-04 | 2015-08-13 | University Of Virginia Patent Foundation | Compositions and methods for analysis of protein sequences and post-translational modifications |
| CN104155457B (zh) | 2014-08-22 | 2016-11-16 | 北京蛋白质组研究中心 | 一种结直肠癌相关“多肽-蛋白组合式标志物”检测试剂盒 |
| CN104345154B (zh) | 2014-08-22 | 2016-10-26 | 北京蛋白质组研究中心 | 一种检测多肿瘤相关“多肽-蛋白组合式标志物”的双抗体夹心试剂盒 |
| WO2016081413A1 (en) * | 2014-11-17 | 2016-05-26 | The Rockefeller University | Compositions and methods for use in diagnosis of alzheimer's disease |
| EP3390439B1 (en) | 2015-12-15 | 2025-03-12 | Takeda Pharmaceutical Company Limited | Peptide quantitation assay for differentiating full-length high molecular weight kininogen (hmwk) and cleaved hmwk |
-
2016
- 2016-12-15 EP EP16825947.1A patent/EP3390439B1/en active Active
- 2016-12-15 IL IL297850A patent/IL297850B2/en unknown
- 2016-12-15 IL IL312919A patent/IL312919B1/en unknown
- 2016-12-15 JP JP2018531159A patent/JP7092669B2/ja active Active
- 2016-12-15 CN CN201680079865.9A patent/CN108602877A/zh active Pending
- 2016-12-15 EA EA201891414A patent/EA201891414A1/ru unknown
- 2016-12-15 IL IL322971A patent/IL322971A/en unknown
- 2016-12-15 KR KR1020247036874A patent/KR102874711B1/ko active Active
- 2016-12-15 AU AU2016372159A patent/AU2016372159B2/en active Active
- 2016-12-15 MX MX2018007493A patent/MX2018007493A/es unknown
- 2016-12-15 CA CA3008621A patent/CA3008621A1/en active Pending
- 2016-12-15 WO PCT/US2016/066936 patent/WO2017106504A1/en not_active Ceased
- 2016-12-15 EP EP25162494.6A patent/EP4597115A3/en active Pending
- 2016-12-15 CO CONC2018/0007216A patent/CO2018007216A2/es unknown
- 2016-12-15 US US16/062,734 patent/US11668718B2/en active Active
- 2016-12-15 KR KR1020187020049A patent/KR102728491B1/ko active Active
- 2016-12-15 NZ NZ743482A patent/NZ743482A/en unknown
-
2018
- 2018-06-13 IL IL259995A patent/IL259995B2/en unknown
- 2018-06-15 MX MX2023000773A patent/MX2023000773A/es unknown
-
2022
- 2022-06-10 AU AU2022204058A patent/AU2022204058B2/en active Active
- 2022-06-16 JP JP2022096962A patent/JP7425117B2/ja active Active
-
2023
- 2023-04-28 US US18/308,813 patent/US12135329B2/en active Active
-
2024
- 2024-01-18 JP JP2024005910A patent/JP7758766B2/ja active Active
- 2024-09-24 US US18/894,192 patent/US20250172567A1/en active Pending
-
2025
- 2025-01-22 AU AU2025200412A patent/AU2025200412A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019505185A5 (enExample) | ||
| JP4505045B2 (ja) | 血液凝固時間の延長原因の判定法 | |
| Caires et al. | Identification of a 14 kDa endocan fragment generated by cathepsin G, a novel circulating biomarker in patients with sepsis | |
| JP2016536012A5 (enExample) | ||
| KR20090023369A (ko) | Ｄ-다이머 및 가용성 피브린 수준 측정에 의한 혈전색전성 정맥 질환의 검출 | |
| US20250172567A1 (en) | Peptide quantitation assay for differentiating full-length high molecular weight kininogen (hmwk) and cleaved hmwk | |
| JP2022141640A5 (enExample) | ||
| US20100055723A1 (en) | Galectin-3-Binding Protein as a Biomarker of Cardiovascular Disease | |
| Aletti et al. | Peptidomic analysis of rat plasma: proteolysis in hemorrhagic shock | |
| da Silva Vaz Junior et al. | Changes in saliva protein profile throughout Rhipicephalus microplus blood feeding | |
| JP2024026847A5 (enExample) | ||
| Sempere et al. | Assessing the short-and long-term prognosis of patients with cirrhosis and acute variceal bleeding | |
| Wosiewicz et al. | Portal vein thrombosis in cirrhosis is not associated with intestinal barrier disruption or increased platelet aggregability | |
| JP2021164678A (ja) | 接触系活性化の評価のためのプロテアーゼ阻害剤を含む真空採血管 | |
| Williams et al. | A bovine model of hypoxia-induced pulmonary hypertension reveals a gradient of immune and matrisome response with a complement signature found in circulation | |
| Liu et al. | Proteomic profiling of the midgut contents of Haemaphysalis flava | |
| WO2016012864A2 (en) | Biomarkers for anderson-fabry disease | |
| EA034043B1 (ru) | Способ определения продуктов деградации пептидов из протеолитического каскада в образцах крови | |
| G. Khadija et al. | Biology and regulatory roles of nuclear lamins in cellular function and dysfunction | |
| Spronk et al. | Theme 2: epidemiology, biomarkers, and imaging of venous thromboembolism (and postthrombotic syndrome) | |
| Dubois et al. | Dipeptidyl peptidase 9 (DPP9) from bovine testes: Identification and characterization as the short form by mass spectrometry | |
| EP1920068A1 (en) | Lupus anticoagulant testing | |
| JP6491880B2 (ja) | 異物表面との接触による血液凝固系の活性化の熱安定性阻害剤 | |
| NZ783522A (en) | Peptide quantitation assay for differentiating full-length high molecular weight kininogen (HMWK) and cleaved HMWK | |
| NZ783522B2 (en) | Peptide quantitation assay for differentiating full-length high molecular weight kininogen (HMWK) and cleaved HMWK |